These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 21178617)

  • 1. Chemoradiation therapy in nonsmall cell lung cancer.
    Baas P; Belderbos JS; van den Heuvel M
    Curr Opin Oncol; 2011 Mar; 23(2):140-9. PubMed ID: 21178617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequencing chemotherapy, radiotherapy and surgery in combined modality treatment of stage III nonsmall cell lung cancer.
    Maas KW; El Sharouni SY; Smit EF; Schramel FM
    Curr Opin Pulm Med; 2007 Jul; 13(4):297-304. PubMed ID: 17534176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of unresectable stage III non-small cell lung cancer: the role of combined chemoradiation.
    Penland SK; Socinski MA
    Semin Radiat Oncol; 2004 Oct; 14(4):326-34. PubMed ID: 15558508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction chemotherapy followed by radical local therapy for locally advanced non-small cell lung cancer.
    Wendland MM; Sause WT
    Semin Surg Oncol; 2003; 21(2):111-21. PubMed ID: 14508861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of locally advanced non-small cell lung cancer.
    Fidler MJ; Kim AW; Zusag T; Bonomi P
    Clin Adv Hematol Oncol; 2009 Jul; 7(7):455-64, 479-80. PubMed ID: 19701153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group.
    Segawa Y; Ueoka H; Kiura K; Kamei H; Tabata M; Sakae K; Hiraki Y; Kawahara S; Eguchi K; Hiraki S; Harada M
    Br J Cancer; 2000 Jan; 82(1):104-11. PubMed ID: 10638975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is concurrent chemoradiation the standard of care for locally advanced non-small cell lung cancer? A review of guidelines and evidence.
    O'Rourke N; Macbeth F
    Clin Oncol (R Coll Radiol); 2010 Jun; 22(5):347-55. PubMed ID: 20427167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chemoradiation therapy: a model for treatment optimization in oncology].
    Mornex F; Girard N; Van Houtte P
    Bull Cancer; 2006 Aug; 93(8):751-60. PubMed ID: 16935779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incorporation of paclitaxel and carboplatin in combined-modality therapy for locally advanced non-small cell lung cancer.
    Belani CP
    Semin Oncol; 1999 Feb; 26(1 Suppl 2):44-54. PubMed ID: 10190783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent chemoradiation using paclitaxel and carboplatin in locally advanced non-small cell lung cancer.
    Langer CJ
    Semin Radiat Oncol; 1999 Apr; 9(2 Suppl 1):108-16. PubMed ID: 10210549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined chemo-radiotherapy for locally advanced non-small cell lung cancer: current status and future development.
    Guida C; Maione P; Rossi A; Bareschino M; Schettino C; Barzaghi D; Elmo M; Gridelli C
    Crit Rev Oncol Hematol; 2008 Dec; 68(3):222-32. PubMed ID: 18632283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Concurrent chemoradiation in lung cancer].
    Girard N; Mornex F
    Bull Cancer; 2005 Dec; 92(12):1048-64. PubMed ID: 16396751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neoadjuvant chemoradiation in non-small cell lung cancer].
    Milleron B; Girard N; Gounant V; Mornex F
    Cancer Radiother; 2007; 11(1-2):36-40. PubMed ID: 17055314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined chemotherapy and radiation in locally advanced non-small cell lung cancer.
    Belani CP; Aisner J
    Semin Oncol; 1994 Jun; 21(3 Suppl 6):79-90. PubMed ID: 8052878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Definitive chemoradiation for the treatment of locally advanced non small-cell lung cancer.
    Blackstock AW; Govindan R
    J Clin Oncol; 2007 Sep; 25(26):4146-52. PubMed ID: 17827465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
    Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
    Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reply to: Is concurrent chemoradiation the standard of care for locally advanced non-small cell lung cancer? A review of guidelines and evidence.
    Faivre-Finn C; Le Pechoux C; Pignon JP; Auperin A
    Clin Oncol (R Coll Radiol); 2011 Feb; 23(1):62-3; author reply 63-4. PubMed ID: 20934861
    [No Abstract]   [Full Text] [Related]  

  • 18. [Recent changes in the management of advanced non-small cell lung cancer].
    Kodama N; Kawahara M; Furuse K
    Gan To Kagaku Ryoho; 1994 Nov; 21(15):2564-70. PubMed ID: 7979414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pattern of failure following chemoradiation for locally advanced non-small cell lung cancer: potential role for stereotactic body radiotherapy.
    Nguyen NP; Bishop M; Borok TJ; Welsh J; Hamilton R; Cohen D; Nguyen LM; Vincent VH
    Anticancer Res; 2010 Mar; 30(3):953-61. PubMed ID: 20393019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combination of chemotherapy and radiotherapy for locally advanced non-small cell lung cancer].
    Fournel P
    Rev Mal Respir; 2007 Oct; 24(8 Pt 2):6S94-100. PubMed ID: 18235400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.